Toward the realization of “4Fs (Firsts)”

As the Chief Executive of PMDA, I will promote “4Fs (First)” listed below:

Patient First

We make well communication with healthcare professional and work giving the highest priority to patient satisfaction.

Access First

We accelerate the access to innovative medical products of public demand, while ensuring appropriate risk-benefit balance.

Safety First

Focusing on risk mitigation, we implement efficient post-marketing data collection and product distribution control, especially for accelerated approval schemes such as “Conditional Early Approval System” and “SAKIGAKE Designation System”.

Asia First

We promote regulatory harmonization and improve public health among Asian countries/regions, as well as build trust in Japanese regulatory system.

June 2019
  
 Yasuhiro Fujiwara, MD, PhD
 Chief Executive
 Pharmaceuticals and Medical Devices Agency